Director Daniel Allen Gold filed a Form 4 with the SEC on November 18, 2026, disclosing sales and in-kind distributions of Roivant Sciences Ltd. common shares held indirectly through QVT-affiliated entities on November 16 and 17, 2026.

Key Highlights

  • Director role: Daniel Allen Gold is identified as a director of Roivant Sciences Ltd. (NASDAQ:ROIV).
  • November 16 sales: QVT Financial Investment Cayman Ltd. disposed of 79,461 shares at $39.17 and 18,927 shares at $38.99; QVT P&E Roiv Hldgs Ltd. disposed of 550,280 shares at $39.17 and 131,073 shares at $38.99.
  • November 17 sales: QVT Financial Investment Cayman Ltd. sold 75,716 shares at $38.24; QVT P&E Roiv Hldgs Ltd. sold 525,507 shares at $38.24; QVT Deferred Compensation Holdings Ltd. sold 798 shares at $38.24.
  • In-kind distributions: On November 17, 2026, each of QVT FIC, QVT P&E, and QVT DCH made an in-kind distribution on a pro rata basis for no consideration, transferring 15,969; 385,620; and 2,635,169 shares, respectively.
  • Post-transaction holdings: Following all reported transactions, QVT Financial Investment Cayman Ltd. held 13,499,093 shares, QVT Deferred Compensation Holdings Ltd. held 5,805,461 shares, and QVT P&E Roiv Hldgs Ltd. held 0 shares, all indirectly.
  • Beneficial ownership disclaimer: Gold disclaims beneficial ownership of the securities held by QVT FIC, QVT P&E, and QVT DCH, except to the extent of his pecuniary interest therein, according to the filing.

Gold's QVT Entities Reduce Roivant Position Across Two Trading Days

According to the filing, all reported transactions involved common shares held indirectly by Gold through three QVT-affiliated entities: QVT Financial Investment Cayman Ltd. (QVT FIC), QVT P&E Roiv Hldgs Ltd. (QVT P&E), and QVT Deferred Compensation Holdings Ltd. (QVT DCH). Gold is described as one of three directors of QVT FIC and one of two directors of each of QVT P&E and QVT DCH, sharing voting and investment control over the shares held directly by each entity.

On November 16, 2026, the filing reports open-market sales (transaction code S) by QVT FIC and QVT P&E at two price points: $39.17 per share and $38.99 per share. Combined, the entities disposed of 98,388 and 681,353 shares at those respective prices. On November 17, 2026, additional sales occurred at $38.24 per share across all three entities, disposing of 75,716 shares from QVT FIC, 525,507 from QVT P&E, and 798 from QVT DCH.

Also on November 17, 2026, the filing records in-kind distributions (transaction code J) at $0.00 per share from each entity on a pro rata basis and for no consideration, as described in the filing's explanation of responses. The filing states that Gold "disclaims beneficial ownership of the securities held by QVT FIC, QVT P&E and QVT DCH, except to the extent of his pecuniary interest therein," and that inclusion of these shares in the report "shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose."

What Was Disclosed

The filing disclosed sales and in-kind distributions of Roivant Sciences Ltd. common shares held indirectly by Director Daniel Allen Gold through three QVT entities on November 16 and 17, 2026, with post-transaction share counts detailed for each entity.